Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets

NCT05637541 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: GST-HG141

Sponsor

Fujian Akeylink Biotechnology Co., Ltd.